Anthem Biosciences debuted on the stock market on July 21, listing at ₹723.05 on NSE, a 26.85% premium over its IPO price. The offering raised ₹3,395.79 crore, attracting a subscription of 67.42 times, with the QIB segment receiving the highest demand at 192.80 times.